ColciGel

Physician Explores Gout Treatment Options

Physician Explores Gout Treatment Options

As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form of inflammatory arthritis and the most common form of this type of arthritis in men, according to Dr. Gary Myerson, a founding fellow of the American College of Rheumatology....
Reduce Patients’ Gout Pain…

Reduce Patients’ Gout Pain…

…“At the Site” and In Their Pocket Chain Drug Review | April 24, 2017 Gensco Pharma Introduces the First Complete Gout Savings Program The innovative ColciGel® Allopurinol Voucher Program offers patients affordable access to ColciGel® for acute gout flares and...
MDose v Tube Study

MDose v Tube Study

MDose™ Technology Background It has been shown that convenience, ease of dispensing and favorable tolerability are key characteristics that may increase patient compliance with topical dermatologic therapy.[1],[2],[3] Additionally, the quantity of drug utilized with...
Medicare (CGDP) Gap Announcement

Medicare (CGDP) Gap Announcement

Gensco Pharma Announces Additions to 2017 CGDP on CMS Gensco products will be available to MEDICARE patients in 2017              
ColciGel®: A Superior Alternative for Acute Gout Flares

ColciGel®: A Superior Alternative for Acute Gout Flares

By Gary E. Myerson, MD, Marc Alan Brenner, DPM, Robert L. Wilbur, Pharm.D., CPh | Director, Medical Affairs
A new agent, ColciGel®, has recently emerged for the treatment of acute flares of gout. ColciGel is a transdermal gel preparation of Colchicinum (colchicine in its homeopathic state) that is applied topically. ColciGel contains Colchicinum 4X in a proprietary Organogel that is applied directly to the site of acute flares.